<DOC>
	<DOC>NCT00901823</DOC>
	<brief_summary>This is a single-center, randomized, open-label, single- and multiple-dose, five-treatment, two-period, four-way parallel study comparing the pharmacokinetics (PK) of Diazoxide Choline Controlled-Release Tablet (DCCR) administered orally under fed and fasting conditions at two dose levels.</brief_summary>
	<brief_title>Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide Choline</brief_title>
	<detailed_description />
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<mesh_term>Choline</mesh_term>
	<mesh_term>Diazoxide</mesh_term>
	<criteria>Signed informed consent Healthy adults Fasting glucose ≤ 125 mg/dL and HbA1C ≤ 6.5 Fasting triglyceride ≥150 mg/dL and ≤ 500 mg/dL Known CAD, DM, uncontrolled HTN Pregnancy or unable to complaint with the birth control method required</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>